A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapy

BACKGROUND: CD161 has been linked to the appearance and development of various cancers. METHODS: The mutation map and the variation of CNVs and SNVs of CD161 were displayed according to cBioportal and GSCALite. We also evaluated the pathway enrichment and drug sensitivity of CD161 according to GSCAL...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, He, Zhou, Ke, Wang, Kaiyue, Cao, Hui, Wu, Wantao, Wang, Zeyu, Dai, Ziyu, Chen, Shi, Peng, Yun, Xiao, Gelei, Luo, Peng, Zhang, Jian, Liu, Zaoqu, Cheng, Quan, Zhang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844218/
https://www.ncbi.nlm.nih.gov/pubmed/36660546
http://dx.doi.org/10.3389/fimmu.2022.1040289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844218/
https://www.ncbi.nlm.nih.gov/pubmed/36660546
http://dx.doi.org/10.3389/fimmu.2022.1040289

Ejemplares similares